Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway

References

• Zha G-F, Qin H-L, Youssif BGM, Amjad MW, Raja MAG, Abdelazeem AH, Bukhari SNA. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance. Eur J Med Chem. 2017;135:34–48.
   PubMed Web of Science ®Google Scholar
• Hisham M, Youssif BGM, Osman EEA, Hayallah AM, Abdel-Aziz M. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents. Eur J Med Chem. 2019;176:117–128.
   PubMed Web of Science ®Google Scholar
• Youssif BGM, Abdelrahman MH, Abdelazeem AH, Abdelgawad MA, Ibrahim HM, Salem OIA, Mohamed MFA, Treambleau L, Bukhari SNA. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production. Eur J Med Chem. 2018;146:260–273.
   PubMed Web of Science ®Google Scholar
• Abou-Zied HA, Youssif BGM, Mohamed MFA, Hayallah AM, Abdel-Aziz M. Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules. Bioorg Chem. 2019;89:102997.
   PubMed Web of Science ®Google Scholar
• El-Sherief HAM, Youssif BGM, Abbas Bukhari SN, Abdelazeem AH, Abdel-Aziz M, Abdel-Rahman HM. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. Eur J Med Chem. 2018;156:774–789.
   PubMed Web of Science ®Google Scholar
• Hughes D, Andersson DI. Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat Rev Genet. 2015;16(8):459–471.
   PubMed Web of Science ®Google Scholar
• Lehár J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF, Staunton JE, Jin X, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009;27(7):659–666.
   PubMed Web of Science ®Google Scholar
• Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Hemmati G, Martins MM, Maynard A, Kuhn J, et al. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med. 2019;25(1):111–118.
   PubMed Web of Science ®Google Scholar
• Umadevi P, Deepti D, Venugopal DVR. Synthesis, anticancer and antibacterial activities of piperine analogs. Med Chem Res. 2013;22(11):5466–5471.
   Web of Science ®Google Scholar
• Deng Y, Sriwiriyajan S, Tedasen A, Hiransai P, Graidist P. Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro. J Ethnopharmacol. 2016;188:87–95.
   PubMed Web of Science ®Google Scholar
• Katz L, Baltz RH. Natural product discovery: past, present, and future. J Ind Microbiol Biotechnol. 2016;43(2–3):155–176.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 2003;66(7):1022–1037.
   PubMed Web of Science ®Google Scholar
• Ali Y, Alam MS, Hamid H, Husain A, Bano S, Dhulap A, Kharbanda C, Nazreen S, Haider S. Design, synthesis, and biological evaluation of piperic acid triazolyl derivatives as potent anti-inflammatory agent. Eur J Med Chem. 2015;92:490–500.
   PubMed Web of Science ®Google Scholar
• Tantawy AH, Meng X-G, Marzouk AA, Fouad A, Abdelazeem AH, Youssif BGM, Jiang H, Wang M-Q. Structure-based design, synthesis, and biological evaluation of novel piperine–resveratrol hybrids as antiproliferative agents targeting SIRT-2. RSC Adv. 2021;11(41):25738–25751.
   PubMed Web of Science ®Google Scholar
• Baraldi PG, Bovero A, Fruttarolo F, Preti D, Tabrizi MA, Pavani MG, Romagnoli R. DNA minor groove binders as potential antitumor and antimicrobial agents. Med Res Rev. 2004;24(4):475–528.
   PubMed Web of Science ®Google Scholar
• Karaaslan C. Synthesis and structure elucidation of new benzimidazole amidoxime derivatives. Turk J of Pharm Sci. 2020;17(1):108–114.
   PubMed Web of Science ®Google Scholar
• Gobis K, Foks H, Kȩdzia A, et al. Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety. Acta Pol Pharm - Drug Res. 2006;63:39–45.
   PubMedGoogle Scholar
• Huang M-R, Hsu Y-L, Lin T-C, Cheng T-J, Li L-W, Tseng Y-W, Chou Y-S, Liu J-H, Pan S-H, Fang J-M, et al. Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer. Eur J Med Chem. 2019;181:111551.
   PubMed Web of Science ®Google Scholar
• Ningaiah S, Bhadraiah UK, Keshavamurthy S, Javarasetty C. Novel pyrazoline amidoxime and their 1, 2, 4-oxadiazole analogues: synthesis and pharmacological screening. Bioorg Med Chem Lett. 2013;23(16):4532–4539.
   PubMed Web of Science ®Google Scholar
• Burgaud JL, Ongini E, Del Soldato P. Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents. Ann N Y Acad Sci. 2002; 962(1):360–371.
   PubMedGoogle Scholar
• Youssif BGM, Gouda AM, Moustafa AH, Abdelhamid AA, Gomaa HAM, Kamal I, Marzouk AA. Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity. J Mol Struct. 2022;1253:132218.
   Web of Science ®Google Scholar
• Obaid Arhema Frejat F, Zhai H, Cao Y, Wang L, Mostafa YA, Gomaa HAM, Youssif BGM, Wu C. Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: synthesis and biological evaluation. Bioorg Chem. 2022;126:105922.
   PubMed Web of Science ®Google Scholar
• Shingate PN, Dongre PP, Kannur DM. New method development for extraction and isolation of piperine from black pepper. IJPSR. 2013;4:3165–3170.
   Google Scholar
• Wang Y, Yao Y, Liu J, Wu L, Liu T, Cui J, Lee DY-W. Synthesis and biological activity of piperine derivatives as potential PPARγ agonists. Drug Des Devel Ther. 2020;14:2069–2078.
   PubMed Web of Science ®Google Scholar
• Youssif BGM, Mohamed MFA, Al-Sanea MM, Moustafa AH, Abdelhamid AA, Gomaa HAM. Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: design, synthesis and docking studies. Bioorg Chem. 2019;85:577–584.
   PubMed Web of Science ®Google Scholar
• Abdelbaset MS, Abdel-Aziz M, Abuo-Rahma GEA et al. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: design, synthesis, antiproliferative and caspase-3 activation activities. Arch Pharm. 2019;352:1800270.
   Web of Science ®Google Scholar
• Al-Wahaibi LH, Gouda AM, Abou-Ghadir OF, Salem OIA, Ali AT, Farghaly HS, Abdelrahman MH, Trembleau L, Abdu-Allah HHM, Youssif BGM, et al. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors. Bioorg Chem. 2020;104:104260.
   PubMed Web of Science ®Google Scholar
• Mohassab AM, Hassan HA, Abdelhamid D, Gouda AM, Youssif BGM, Tateishi H, Fujita M, Otsuka M, Abdel-Aziz M. Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases. Bioorg Chem. 2021;106:104510.
   PubMed Web of Science ®Google Scholar
• Marzouk AA, Abdel-Aziz SA, Abdelrahman KS, Wanas AS, Gouda AM, Youssif BGM, Abdel-Aziz M. Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: molecular docking and antiproliferative evaluation. Bioorg Chem. 2020;102:104090.
   PubMed Web of Science ®Google Scholar
• Mohamed FAM, Gomaa HAM, Hendawy OM, Ali AT, Farghaly HS, Gouda AM, Abdelazeem AH, Abdelrahman MH, Trembleau L, Youssif BGM, et al. Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity. Bioorg Chem. 2021;112:104960.
   PubMed Web of Science ®Google Scholar
• El-Sherief HAM, Youssif BGM, Bukhari SNA, Abdel-Aziz M, Abdel-Rahman HM. Novel 1,2,4-triazole derivatives as potential anticancer agents: design, synthesis, molecular docking and mechanistic studies. Bioorg Chem. 2018;76:314–325.
   PubMed Web of Science ®Google Scholar
• Mekheimer RA, Allam SMR, Al-Sheikh MA, Moustafa MS, Al-Mousawi SM, Mostafa YA, Youssif BGM, Gomaa HAM, Hayallah AM, Abdelaziz M, et al. Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: rapid synthesis, docking, and ADME studies. Bioorg Chem. 2022;121:105693.
   PubMed Web of Science ®Google Scholar
• Gomaa HAM, Shaker ME, Alzarea SI, Hendawy OM, Mohamed FAM, Gouda AM, Ali AT, Morcoss MM, Abdelrahman MH, Trembleau L, et al. Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities. Bioorg Chem. 2022;120:105616.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.
   Google Scholar
• Abdel-Wahab NM, Gomaa AA, Mostafa YA, et al. Diterpenoids profile of the marine sponge Chelonaplysilla erecta and candidacy as potential ‎antitumor drugs investigated by molecular docking and pharmacokinetic studies. Nat Prod ‎Res. 2022;36(20):1–5.
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000;44(1):235–249.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery ‎Rev. 1997;23(1-3):3–25.
   Web of Science ®Google Scholar
• Martin YC. A bioavailability score. J Med Chem. 2005;48(9):3164–3170.
   PubMed Web of Science ®Google Scholar